[Local injection of bleomycin A5 in lymphangioma in children. Analysis of 100 cases].
From Jan. 1985 to Dec. 1988, 100 newborn and small infants suffering from lymphangioma were treated with bleomycin A5 injecting into lymphangioma. The cases were divided into three types: (1) Bleomycin A5 local injection into the lymphangioma were practiced on 70 cases; (2) Surgical partial resection of lymphangioma plus local injection on 26 cases; (3) A previous excision but recurred postoperatively were 4 cases. The dosage of bleomycin A5 was 10 mg per time. The therapeutic course was not more than 5 times. The efficacy of bleomycin A5 were satisfactory in all cases except only one case with a large lymphangioma of previous palliative excision but recurred. There was not a recurrent patient at following-up from 3 months to 4 years.
Jiang
J P
JP
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015552:Injections, Intralesional; D008202:Lymphangioma / Q000188:drug therapy*; D008297:Male
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; C025703:bleomycetin